These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1028 related items for PubMed ID: 18546285

  • 21. The analgesic effect of botulinum-toxin A on postwhiplash neck pain.
    Braker C, Yariv S, Adler R, Badarny S, Eisenberg E.
    Clin J Pain; 2008 Jan; 24(1):5-10. PubMed ID: 18180629
    [Abstract] [Full Text] [Related]

  • 22. Electroacupuncture is not effective in chronic painful neuropathies.
    Penza P, Bricchi M, Scola A, Campanella A, Lauria G.
    Pain Med; 2011 Dec; 12(12):1819-23. PubMed ID: 21917117
    [Abstract] [Full Text] [Related]

  • 23. The effects of botulinum toxin A on mechanical and cold allodynia in a rat model of neuropathic pain.
    Park HJ, Lee Y, Lee J, Park C, Moon DE.
    Can J Anaesth; 2006 May; 53(5):470-7. PubMed ID: 16636031
    [Abstract] [Full Text] [Related]

  • 24. Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial.
    Sahai A, Dowson C, Khan MS, Dasgupta P.
    BJU Int; 2009 Jun; 103(11):1509-15. PubMed ID: 19389019
    [Abstract] [Full Text] [Related]

  • 25. Antihyperalgesic and analgesic properties of the N-methyl-D-aspartate (NMDA) receptor antagonist neramexane in a human surrogate model of neurogenic hyperalgesia.
    Klein T, Magerl W, Hanschmann A, Althaus M, Treede RD.
    Eur J Pain; 2008 Jan; 12(1):17-29. PubMed ID: 17449306
    [Abstract] [Full Text] [Related]

  • 26. Spinal administration of a delta opioid receptor agonist attenuates hyperalgesia and allodynia in a rat model of neuropathic pain.
    Holdridge SV, Cahill CM.
    Eur J Pain; 2007 Aug; 11(6):685-93. PubMed ID: 17175187
    [Abstract] [Full Text] [Related]

  • 27. Botulinum toxin type A for neuropathic pain in patients with spinal cord injury.
    Han ZA, Song DH, Oh HM, Chung ME.
    Ann Neurol; 2016 Apr; 79(4):569-78. PubMed ID: 26814620
    [Abstract] [Full Text] [Related]

  • 28. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
    Vadoud-Seyedi J, Simonart T.
    Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
    [Abstract] [Full Text] [Related]

  • 29. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
    Elovic EP, Brashear A, Kaelin D, Liu J, Millis SR, Barron R, Turkel C.
    Arch Phys Med Rehabil; 2008 May; 89(5):799-806. PubMed ID: 18452724
    [Abstract] [Full Text] [Related]

  • 30. Quantitative sensory testing of patients with long lasting Patellofemoral pain syndrome.
    Jensen R, Hystad T, Kvale A, Baerheim A.
    Eur J Pain; 2007 Aug; 11(6):665-76. PubMed ID: 17204440
    [Abstract] [Full Text] [Related]

  • 31. Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin.
    Gazerani P, Pedersen NS, Staahl C, Drewes AM, Arendt-Nielsen L.
    Pain; 2009 Jan; 141(1-2):60-9. PubMed ID: 19004549
    [Abstract] [Full Text] [Related]

  • 32. [Botulinum toxin and painful peripheral neuropathies: what should be expected?].
    Ranoux D.
    Rev Neurol (Paris); 2011 Jan; 167(1):46-50. PubMed ID: 21194720
    [Abstract] [Full Text] [Related]

  • 33. Botulinum toxin type A injection in alleviating postoperative pain and improving quality of life in lower extremity limb lengthening and deformity correction: a pilot study.
    Hamdy RC, Montpetit K, Raney EM, Aiona MD, Fillman RR, MacKenzie W, McCarthy J, Chafetz RS, Thomas SS, Tamayo CM, Littleton AG, Ruck-Gibis J, Takahashi SN, Rinaldi M, Finley GA, Platt RW, Dahan-Oliel N.
    J Pediatr Orthop; 2009 Jan; 29(5):427-34. PubMed ID: 19568011
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crow's feet.
    Lowe NJ, Lask G, Yamauchi P, Moore D.
    J Am Acad Dermatol; 2002 Dec; 47(6):834-40. PubMed ID: 12451366
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain.
    Leung A, Wallace MS, Ridgeway B, Yaksh T.
    Pain; 2001 Mar; 91(1-2):177-87. PubMed ID: 11240090
    [Abstract] [Full Text] [Related]

  • 39. Lack of analgesia by oral standardized cannabis extract on acute inflammatory pain and hyperalgesia in volunteers.
    Kraft B, Frickey NA, Kaufmann RM, Reif M, Frey R, Gustorff B, Kress HG.
    Anesthesiology; 2008 Jul; 109(1):101-10. PubMed ID: 18580179
    [Abstract] [Full Text] [Related]

  • 40. Characterization of chronic constriction of the saphenous nerve, a model of neuropathic pain in mice showing rapid molecular and electrophysiological changes.
    Walczak JS, Pichette V, Leblond F, Desbiens K, Beaulieu P.
    J Neurosci Res; 2006 May 15; 83(7):1310-22. PubMed ID: 16511871
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 52.